Novavax utilizes a standardized vaccine approach, similar to the shingles and hepatitis vaccines that have been out for many years. It's a tried and true platform. Recently, the company received their first EUA in Indonesia and is applying in other countries.
They have asked for a meeting with the FDA to discuss the application here in the United States and hopes to submit by end of year.
If the FDA is serious in ending this pandemic, they will FASTLINE the vaccine.
If the FDA is deep in the pockets of Pfizer and Moderna, they will slow track the process or outright refuse the EUA and make them apply for standard approval stating "there's already sufficient supply of vaccine". Standard approval takes years.
So watch it closely and I think this will reveal what's really going on.
[link] [comments]
CURRENT BURN: 390,738,863
NEXT ACTIVATION: 400,000,000
VAULT ACCESS
Comments
Post a Comment